Healthcare iPledge Consent Form
What the Healthcare iPledge Consent Form Is
Why this Consent Form Matters for Care and Compliance
A clear, signed iPledge-style consent protects patient autonomy, documents clinical risk counseling, and creates an auditable record for providers and pharmacies. Proper completion minimizes medication errors, supports regulatory reporting, and helps demonstrate compliance with HIPAA and applicable REMS program rules.
Which Professionals and Patients Complete This Form
The form is used by multiple clinical and administrative roles across outpatient care settings; each party has distinct responsibilities before medication is dispensed.
- Prescribers and clinicians who obtain informed consent and document counseling and eligibility.
- Pharmacists verifying program enrollment and confirming required attestations before dispensing.
- Practice administrators or REMS coordinators who manage registry submissions and record retention.
Patients also complete sections attesting to understanding, pregnancy-testing status when applicable, and consent to share required clinical data with authorized program registries and pharmacies.
Step-by-Step: Completing the Consent Form
-
011. Review: Read entire form and disclosure language.
-
022. Fill Details: Enter patient and clinical data accurately.
-
033. Verify Identity: Confirm ID and any required test results.
-
044. Sign & Submit: Obtain signatures and route to registry/pharmacy.
How to Configure an Online iPledge Consent Workflow
| Field | Configuration |
|---|---|
| Authentication | Email + SMS OTP or organization SSO |
| Recipient Routing | Provider -> Pharmacy -> Registry copy |
| Conditional Fields | Show pregnancy fields for patients of childbearing potential |
| Audit Trail | Enable timestamping and event logging |
Where the Completed Form Typically Flows
-
Electronic Health Record: Attach signed PDF to the patient chart
-
Pharmacy: Send verified consent before medication dispensing
-
REMS/Registry: Submit required attestation fields to the program registry
-
Patient Copy: Provide signed copy to patient for their records
Technical and Integration Requirements
Confirm platform support for PDF, DOCX, and secure audit logs, and verify available integrations to avoid manual re‑entry.
- Formats: PDF, DOCX, HTML supported
- Integrations: Salesforce, Microsoft 365, NetSuite, Google Workspace
- Accessibility: WCAG 2.0 Level AA compatibility
When PHI is involved, require a signed BAA with the eSignature vendor and confirm encryption, audit trails, and role-based access before transmitting any protected data.
Key Timing Considerations for Signing and Testing
Before First Dose:
Consent must be signed prior to dispensing the medication
Pregnancy Test Window:
Follow the REMS or prescriber-specified testing interval
Prescription Renewal:
Complete updated consent at each renewal per clinic policy
Adverse Event Reporting:
Report serious events per institutional policy and REMS requirements
Registry Submission:
Submit required fields according to the program's schedule
Typical Processing Milestones
Intake and Consent
Patient review and form completion before treatment
Identity Verification
Confirm ID and enter verification details into the form
Clinical Authorization
Prescriber signs attestation and authorizes dispensing
Record Filing
Signed form uploaded to EHR and registry as needed
Common Mistakes to Avoid
- Entering inconsistent patient identifiers across the form and EHR, which can prevent matching with pharmacy or registry records and delay dispensing.
- Failing to complete required conditional fields (for example, pregnancy attestations) that are necessary for program eligibility and pharmacy verification.
- Using informal date formats or missing dates, causing ambiguity in effective dates and testing windows required by clinical programs.
- Not executing a proper identity authentication step for electronic signing, which can weaken the legal defensibility of the consent.
Risks and Potential Consequences of Incorrect Forms
Comparing eSignature Vendors for Healthcare Consent Workflows
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial, no card required | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No envelope cap | 100 envelopes/user/year | Varies | Varies | Varies |
Frequently Asked Questions and Troubleshooting
-
Can this consent be signed electronically?
Yes. Electronic signatures are legally enforceable under the ESIGN Act (15 U.S.C. §7001) and UETA when the signature demonstrates intent and the record is retained. Ensure any consumer-facing disclosure required under 15 U.S.C. §7001(c) is presented before obtaining consent.
-
Do I need a notary or witnesses?
Notarization or witness requirements depend on state law and the specific program. Some states require notarization or witnesses for certain consents; check local rules before relying on an electronic-only signature.
-
How do I protect patient privacy when using eSignature?
Limit access with role-based controls, enable encryption in transit and at rest (TLS 1.2+/AES-256), and require a signed BAA from the eSignature provider when PHI is processed or stored.
-
What if the patient cannot sign electronically?
Offer an in-person paper alternative with a witnessed signature or use a supervised in-person electronic signing kiosk. Maintain evidence of consent and follow the same retention rules as electronic records.
-
Can the consent be revoked?
Yes. Include revocation procedures in the consent form and document any revocation in the patient record; follow clinical and legal guidance for stopping or altering therapy.
-
Which eSignature plan supports bulk sending and HIPAA?
Plans differ by vendor. signNow and some enterprise offerings provide bulk send and HIPAA-compliant options (BAA required); consult vendor plan details for specific feature availability and limits.